Ottobock virtual symposium for healthcare professionals.
NeuroMobility in real-life settings: Clinical and Patient Insights on Exopulse Mollii Suit and C-Brace.
Join us for an exciting online symposium exploring the latest research advancements in NeuroMobility, highlighting new results with C-Brace and Exopulse Mollii Suit.
The “NeuroMobility in real-life settings: Clinical and Patient Insights on Exopulse Mollii Suit and C-Brace” symposium will cover the following key topics:
Research insights on real-world safety and effectiveness data with C-Brace from the US: Gain valuable insights on the use of the C-Brace – with proven improvements in fast walking speed, balance confidence while reducing both falls and the risk of falling.
C-Brace patient experience: Gain insight on impact of Stance Control Orthosis (SCO) and Swing and Stance Control Orthosis (SSCO).
Research Insights on Exopulse Mollii Suit in Multiple Sclerosis: Discover preliminary results on the upper and lower motor function with Exopulse Mollii Suit intervention in a real-life setting.
Don’t miss this opportunity to stay at the forefront of innovation in individuals with neurological impairments. Together, we can enhance patient care and continue driving progress in the field.
Virtual Symposium.
Tuesday 16th, September 2025, 16.00 – 17.30 CET
16.00 | Welcome and Introduction Dr. Andreas Hahn |
16:05 | Increased mobility and reductions in falls after one year of use with a Microprocessor Stance and Swing Control Orthosis: Initial results from the International C-Brace Registry. Russell Lundstrom, BAEM, MSMOT, RAC |
16:25 | SCO vs. SSCO: Where Traditional Stability Meets Smart Mobility. Christiaan Mertens
|
16:45 | Effects of the Exopulse Mollii Suit on motor function in persons with Multiple Sclerosis having ataxia and/or spasticity – preliminary pilot data. Lars Hvid, PhD |
17:05 | Panel Discussion |
17:30 | Wrap up and Closing |
Registration for this virtual symposium.
After completing the registration process successfully, the link to watch the symposium will be promptly sent to the e-mail address provided during registration.
Dr. Andreas Hahn
Vice-président de la recherche clinique et des services, Otto Bock Healthcare Products GmbH – Vienne (Autriche)
Le Dr Hahn est vice-président de la recherche clinique et des services chez Otto Bock, où il dirige la stratégie et la mise en œuvre mondiales de la recherche clinique de l’entreprise.
Titulaire d’un doctorat en physique de l’Université d’Oxford, le Dr Hahn apporte plus de 25 ans d’expérience de direction dans l’industrie des dispositifs médicaux.
Tout au long de sa carrière, il a été reconnu pour ses contributions à la recherche en prothèses, recevant le prestigieux AOPA Thranhardt Lecture Award en 2014, 2019 et 2021. Ses travaux primés comprennent des études sur l’influence de l’évaluation du niveau de mobilité dans la réponse des déambulateurs communautaires limités aux MPK et l’utilisation d’instruments économiques de la santé dans les prothèses.
Russell Lundstrom, BAEM, MSMOT, RAC
Director of Clinical Research & Services – North America; Otto Bock HealthCare LP, Austin, TX
Increased mobility and reductions in falls after one year of use with a Microprocessor Stance and Swing Control Orthosis: Initial results from the International C-Brace Registry.
Russell Lundstrom serves as Director of Clinical Research and Services at Ottobock North America, where he is responsible for the development and execution of clinical studies to drive reimbursement and to accelerate market adoption since 2012. He holds a Master’s degree in Management of Technology (2007) following a Bachelor’s degree in Aerospace Engineering and Mechanics (1998), both from the University of Minnesota.
With over 30 years of experience in the medical device sector, Mr. Lundstrom brings a robust background in clinical trial management, regulatory strategy, and health technology evaluation and the analysis of clinical data to demonstrate product safety and efficacy. His work focuses on the design and execution of clinical investigations for advanced prosthetic and orthotic technologies, with a strong emphasis on generating evidence to support reimbursement pathways and accelerate clinical adoption. Throughout his career, he has collaborated effectively with regulatory agencies, cross-disciplinary teams, and key opinion leaders to align innovation with patient outcomes and commercial strategy.
His contributions to the field have been recognized with multiple Thranhardt Awards (AOPA 2024; AAOP & AOPA 2025), and he recently earned Regulatory Affairs Certification (2025), underscoring his commitment to excellence and innovation in clinical research and medical technology.
Christiaan Mertens
Clinical Expert Orthotics at VIGO ottobock.care, Wetteren, Belgium
SCO vs. SSCO: Where Traditional Stability Meets Smart Mobility.
Christiaans Mertens professional journey began in 2011, when he was working as a prosthetist at Spronken, Belgium. Drawn by an early fascination with prosthetics and determined to join Ottobock one day, he had already devoted himself to orthopedic studies from age 16 to 21.
After gaining hands-on clinical experience at Spronken, he joined as an accountmanager to Ottobock Benelux. Two-and-a-half years later, in 2017, he transitioned into a technical sales position focused on orthotics, where he served with enthusiasm and growing expertise.
When Ottobock expanded direct patient care services in Belgium, it broadened his outlook on how he could contribute. In 2022, he secured the role of Clinical Expert in Orthotics. Christiaan continues to hold this position today at Vigo Ottobock Care, combining clinical insight with a dedication to improving patients’ lives.
Lars Hvid, PhD
Associate Professor, Aarhus University, Dept. of Public Health, Exercise Biology, Denmark
Senior Researcher, The Danish MS Hospitals, Ry and Haslev, Denmark
Effects of the Exopulse Mollii Suit on motor function in persons with Multiple Sclerosis having ataxia and/or spasticity – preliminary pilot data.
Lars Hvid PhD serves as an Associate Professor at Aarhus University, Denmark, and Senior Researcher at the Danish MS Hospital. He holds a PhD in Physical Education and Health from the University of Southern Denmark (2011), following a Master’s in the same field (2008).
As a clinical exercise physiologist, he primarily works with physical exercise and multi-disciplinary (neuro)rehabilitation, and how this can benefit persons with different neurodegenerative conditions. His research focuses on (1) the effects of multi-disciplinary rehabilitation in Multiple Sclerosis and other neurodegenerative populations, (2) the interaction between Multiple Sclerosis and Aging and how this influences different outcomes within the ICF model, and (3) the effects of different exercise modalities and how this can be used as ‘treatment’ across different neurodegenerative conditions.
Dr. Hvid’s expertise spans aging and neurodegenerative disorders, exercise science, physical activity, and multi-disciplinary rehabilitation in clinical populations. He is especially recognized for investigating neuromuscular function including underlying biological mechanisms such as neuroplasticity and neurotrophic factors, and for translating these insights into functional outcomes like walking capacity as well as quality of life.
With over 100 peer-reviewed publications and thousands of citations across platforms (Google Scholar: 4627 citations, H-index: 34), Dr. Hvid is a prolific contributor to the scientific community. His work includes original research, editorials, study protocols, and commentary—reflecting both depth and impact in the field of clinical rehabilitation and neurophysiology.
